No Venous Thromboembolism Increase Among Transgender Female Patients Remaining on Estrogen for Gender Affirming Surgery.

CONCLUSIONS: Peri-operative VTE was not a significant risk in a large, homogenously treated cohort of TGNB patients independent of whether or not hormone therapy was suspended prior to surgery.
PMID: 33417686 [PubMed - as supplied by publisher]

Source: The Journal of Clinical Endocrinology and Metabolism - January 8, 2021 Category: Endocrinology Authors: Kozato A, Fox GWC, Yong PC, Shin SJ, Avanessian BK, Ting J, Ling Y, Karim S, Safer JD, Pang JH Tags: J Clin Endocrinol Metab Source Type: research